文献速递流行病学与生物统计真实世界研究与卫生经济

在地理分布多样的诊所中纳入照护的HIV暴露婴儿的临床与项目结局(1997-2021年):一项队列研究

Clinical and programmatic outcomes of HIV-exposed infants enrolled in care at geographically diverse clinics, 1997-2021: A cohort study.
PubMed 文献 · PLoS Med · 2022-09-15

该回顾性队列研究分析了1997-2021年10个国家198家诊所的82,067名HIV暴露婴儿,评估至24月龄的DNA PCR检测、失访、HIV诊断和死亡的累积发生率。各区域结局差异显著,失访率普遍较高,母婴抗逆转录病毒治疗与婴儿死亡和HIV诊断风险降低相关。

要点

  • 各区域24月龄失访累积发生率从EA的56.2%到WA的98.5%,普遍较高且未随时间改善。
  • 母婴ART与EA婴儿死亡风险降低相关(sdHR 0.65)及HIV诊断风险降低相关(sdHR 0.40)。
  • EA的HIV诊断累积发生率随时间下降至2020年的2.9%。

核心结论

  • 尽管临床和项目结局存在显著的区域和时间异质性,所有区域和时期的婴儿失访率均较高,需进一步努力使HIV暴露婴儿留在照护中。

研究设计与样本

  • 回顾性队列分析,纳入1997-2021年在5个IeDEA区域10个国家198家诊所<18月龄入组的82,067名HIV暴露婴儿。

主要发现

  • 24月龄DNA PCR检测累积发生率从WA的12.3%(95% CL 11.2%,13.5%)到EA的94.8%(95% CL 94.6%,95.1%)。
  • 24月龄失访累积发生率从EA的56.2%(95% CL 55.2%,57.1%)到WA的98.5%(95% CL 98.3%,98.7%)。
  • 24月龄HIV诊断累积发生率从WA的1.9%(95% CL 1.6%,2.3%)到EA的10.3%(95% CL 9.7%,10.9%)。
  • 24月龄死亡累积发生率从CCASAnet的0.5%(95% CL 0.2%,1.0%)到EA的4.7%(95% CL 4.4%,5.0%)。
  • EA中母亲ART与婴儿死亡风险降低相关(sdHR 0.65; 95% CL 0.47,0.91),CA中为sdHR 0.51(95% CL 0.36,0.74);EA中与HIV诊断风险降低相关(sdHR 0.40; 95% CL 0.31,0.50),CA中为sdHR 0.41(95% CL 0.31,0.54)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 真实世界服务提供数据中结局可能存在错误分类。
  • IeDEA站点及其服务的HIV暴露婴儿人群可能不具代表性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although 1·3 million women with HIV give birth annually, care and outcomes for HIV-exposed infants remain incompletely understood. We analyzed programmatic and health indicators in a large, multidecade global dataset of linked mother-infant records from clinics and programs associated with the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium. METHODS AND FINDINGS: HIV-exposed infants were eligible for this retrospective cohort analysis if enrolled at <18 months at 198 clinics in 10 countries across 5 IeDEA regions: East Africa (EA), Central Africa (CA), West Africa (WA), Southern Africa (SA), and the Caribbean, Central, and South America network (CCASAnet). We estimated cumulative incidences of DNA PCR testing, loss to follow-up (LTFU), HIV diagnosis, and death through 24 months of age using proportional subdistribution hazard models accounting for competing risks. Competing risks were transfer, care withdrawal, and confirmation of negative HIV status, along with LTFU and death, when not the outcome of interest. In CA and EA, we quantified associations between maternal/infant characteristics and each outcome. A total of 82,067 infants (47,300 EA, 10,699 CA, 6,503 WA, 15,770 SA, 1,795 CCASAnet) born from 1997 to 2021 were included. Maternal antiretroviral therapy (ART) use during pregnancy ranged from 65·6% (CCASAnet) to 89·5% (EA), with improvements in all regions over time. Twenty-four-month cumulative incidences varied widely across regions, ranging from 12·3% (95% confidence limit [CL], 11·2%,13·5%) in WA to 94·8% (95% CL, 94·6%,95·1%) in EA for DNA PCR testing; 56·2% (95% CL, 55·2%,57·1%) in EA to 98·5% (95% CL, 98·3%,98·7%) in WA for LTFU; 1·9% (95% CL, 1·6%,2·3%) in WA to 10·3% (95% CL, 9·7%,10·9%) in EA for HIV diagnosis; and 0·5% (95% CL, 0·2%,1·0%) in CCASAnet to 4·7% (95% CL, 4·4%,5·0%) in EA for death. Although infant retention did not improve, HIV diagnosis and death decreased over time, and in EA, the cumulative incidence of HIV diagnosis decreased substantially, declining to 2·9% (95% CL, 1·5%,5·4%) in 2020. Maternal ART was associated with decreased infant mortality (subdistribution hazard ratio [sdHR], 0·65; 95% CL, 0·47,0·91 in EA, and sdHR, 0·51; 95% CL, 0·36,0·74 in CA) and HIV diagnosis (sdHR, 0·40; 95% CL, 0·31,0·50 in EA, and sdHR, 0·41; 95% CL, 0·31,0·54 in CA). Study limitations include potential misclassification of outcomes in real-world service delivery data and possible nonrepresentativeness of IeDEA sites and the population of HIV-exposed infants they serve. CONCLUSIONS: While there was marked regional and temporal heterogeneity in clinical and programmatic outcomes, infant LTFU was high across all regions and time periods. Further efforts are needed to keep HIV-exposed infants in care to receive essential services to reduce HIV infection and mortality.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Edmonds A, Brazier E, Musick BS, et al. Clinical and programmatic outcomes of HIV-exposed infants enrolled in care at geographically diverse clinics, 1997-2021: A cohort study. PLoS Med. 2022. PMID: 36107857. doi:10.1371/journal.pmed.1004089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。